IOSP (Innospec) EBIT: $145 Mil (TTM As of Mar. 2026)


IOSP Innospec Inc IOSP
76 GF Score
Price $83.44
GF Value $94.97
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Innospec EBIT?

Innospec IOSP +1.93% 76 EBIT is $145 Mil as of Mar. 2026. GuruFocus rates IOSP with a GF Score™ of 76/100 and a GF Value™ of $94.97 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Innospec's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $32 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $145 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Innospec's annualized ROC % for the quarter that ended in Mar. 2026 was 8.09%. Innospec's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 17.75%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Innospec's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 7.96%.


Innospec  (NAS:IOSP) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Innospec's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=127.2 * ( 1 - 22.81% )/( (1207.6 + 1218.6)/ 2 )
=98.18568/1213.1
=8.09 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Innospec's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=127.2/( ( (338.8 + max(367.9, 0)) + (336.3 + max(390.3, 0)) )/ 2 )
=127.2/( ( 706.7 + 726.6 )/ 2 )
=127.2/716.65
=17.75 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(342.3 + 329.3 + 40.5) - (332.3 + 0 + 11.9)
=367.9

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(354.2 + 321.5 + 34.3) - (312.1 + 0 + 7.6)
=390.3

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Innospec's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=145/1822.687
=7.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innospec EBIT Related Terms


Innospec EBIT Historical Data

* Premium members only.

The historical data trend for Innospec's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innospec EBIT Chart

Innospec Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 130.30 187.30 161.60 181.10 156.30

Innospec Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.10 35.00 31.10 47.10 31.80

IOSP vs NGVT, MTX, LWLG: EBIT Comparison

For the Specialty Chemicals subindustry, Innospec's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innospec EV-to-EBIT vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Innospec's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Innospec's EV-to-EBIT falls into.


IOSP
76GF Score
Innospec Inc IOSP
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innospec EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $145 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $145 Mil mean?
Innospec (IOSP) has a EBIT of $145 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Innospec.
Is Innospec's EBIT too high?
Innospec's current EBIT is $145 Mil. Overall, Innospec has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Innospec's EBIT compare to NGVT and MTX?
Innospec's EBIT of $145 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Chemicals company?
A good EBIT depends on the Chemicals industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Innospec. Innospec's current EBIT is $145 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innospec stock overvalued right now?
Based on GuruFocus' analysis, Innospec (IOSP) is currently considered Modestly Undervalued. The stock's GF Value™ is $94.97, compared to a current price of $83.44 — trading 12.1% below its estimated fair value. The current EBIT is $145 Mil. Innospec's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Innospec (IOSP), the current EBIT is $145 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Innospec (IOSP) Overvalued in 2026?

Based on GuruFocus' analysis, Innospec stock appears to be undervalued. The current stock price of $83.44 is trading 12.1% below its estimated GF Value™ of $94.97. GuruFocus considers Innospec to be Modestly Undervalued.

Key valuation signals for IOSP:

  • EBIT: $145 Mil
  • GF Value™: $94.97 vs. price of $83.44 (12.1% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the IOSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Innospec Business Description

Other Exchanges 0JAX:UKOCT:Germany
Address 8310 South Valley Highway, Suite 350, Englewood, CO, USA, 80112
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.
76GF Score

Get the complete analysis for IOSP

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$83.44
Price
$94.97
GF Value